Clinical Trials in Illinois

Showing 5141-5160 of 14,943 trials

Dissemination of the Cardiovascular Risk Service

NCT03660631

The objective of this study is to evaluate the implementation of of a remote, pharmacist-led cardiovascular risk service (CVRS) in 12 large, organizationally and culturally diverse hospitals and health-systems, many with high proportions of minority and underserved patients.

HypertensionDiabetes Mellitus

Korey Kennelty542 participantsStarted Sep 2018

Pocatello, Idaho, United States • Chicago, Illinois, United States • Mahomet, Illinois, United States +11 more locations

COMPLETEDPhase 251 miles

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

NCT05409235

This study will evaluate the safety and efficacy of OTT166 Ophthalmic solution in participants with Diabetic Retinopathy.

Diabetic Retinopathy

OcuTerra Therapeutics, Inc.225 participantsStarted Jul 2022

Peoria, Arizona, United States • Phoenix, Arizona, United States • Beverly Hills, California, United States +65 more locations

Dissemination of the Cardiovascular Risk Service

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

Find Trials by Condition in Illinois

A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease

Eptinezumab in Participants With Episodic Cluster Headache

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations

A Study of ZN-c5 in Subjects With Breast Cancer

Voxelotor Brain Oxygenation and Neurocognitive Study

A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma

HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis

A Research Study of How Well Macimorelin Works to Find Out if Children Have a Lack of Growth Hormone and How Safe it is

An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)

Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program

Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for Major Depressive Disorder (MDD)